• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在流行国家扩大对成年恰加斯病患者全面护理的获取途径的策略:玻利维亚恰加斯病平台

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform.

作者信息

Pinazo Maria-Jesus, Pinto Jimy, Ortiz Lourdes, Sánchez Jareth, García Wilson, Saravia Ruth, Cortez Mirko-R, Moriana Silvia, Grau Enric, Lozano Daniel, Gascon Joaquim, Torrico Faustino

机构信息

International Health Department, ISGlobal, Barcelona Center for International Health Research, (CRESIB), Hospital Clínic-Universitat de Barcelona, Spain.

Fundación CEADES, Cochabamba, Bolivia.

出版信息

PLoS Negl Trop Dis. 2017 Aug 18;11(8):e0005770. doi: 10.1371/journal.pntd.0005770. eCollection 2017 Aug.

DOI:10.1371/journal.pntd.0005770
PMID:28820896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5576759/
Abstract

BACKGROUND

Bolivia has the highest prevalence of Chagas disease (CD) in the world (6.1%), with more than 607,186 people with Trypanosoma cruzi infection, most of them adults. In Bolivia CD has been declared a national priority. In 2009, the Chagas National Program (ChNP) had neither a protocol nor a clear directive for diagnosis and treatment of adults. Although programs had been implemented for congenital transmission and for acute cases, adults remained uncovered. Moreover, health professionals were not aware of treatment recommendations aimed at this population, and research on CD was limited; it was difficult to increase awareness of the disease, understand the challenges it presented, and adapt strategies to cope with it. Simultaneously, migratory flows that led Bolivian patients with CD to Spain and other European countries forced medical staff to look for solutions to an emerging problem.

INTERVENTION

In this context, thanks to a Spanish international cooperation collaboration, the Bolivian platform for the comprehensive care of adults with CD was created in 2009. Based on the establishment of a vertical care system under the umbrella of ChNP general guidelines, six centres specialized in CD management were established in different epidemiological contexts. A common database, standardized clinical forms, a and a protocolized attention to adults patients, together with training activities for health professionals were essential for the model success. With the collaboration and knowledge transfer activities between endemic and non-endemic countries, the platform aims to provide care, train health professionals, and create the basis for a future expansion to the National Health System of a proven model of care for adults with CD.

RESULTS

From 2010 to 2015, a total of 26,227 patients were attended by the Platform, 69% (18,316) were diagnosed with T. cruzi, 8,567 initiated anti-parasitic treatment, more than 1,616 health professionals were trained, and more than ten research projects developed. The project helped to increase the number of adults with CD diagnosed and treated, produce evidence-based clinical practice guidelines, and bring about changes in policy that will increase access to comprehensive care among adults with CD. The ChNP is now studying the Platform's health care model to adapt and implement it nationwide.

CONCLUSIONS

This strategy provides a solution to unmet demands in the care of patients with CD, improving access to diagnosis and treatment. Further scaling up of diagnosis and treatment will be based on the expansion of the model of care to the NHS structures. Its sustainability will be ensured as it will build on existing local resources in Bolivia. Still human trained resources are scarce and the high staff turnover in Bolivia is a limitation of the model. Nevertheless, in a preliminary two-years-experience of scaling up this model, this limitations have been locally solved together with the health local authorities.

摘要

背景

玻利维亚是世界上恰加斯病(CD)患病率最高的国家(6.1%),有超过607,186人感染克氏锥虫,其中大多数为成年人。在玻利维亚,恰加斯病已被宣布为国家重点疾病。2009年,恰加斯病国家项目(ChNP)既没有针对成年人诊断和治疗的方案,也没有明确的指导方针。尽管已经实施了针对先天性传播和急性病例的项目,但成年人仍然未得到覆盖。此外,卫生专业人员并不了解针对这一人群的治疗建议,而且关于恰加斯病的研究有限;难以提高对该疾病的认识、理解其所带来的挑战以及调整应对策略。与此同时,导致玻利维亚恰加斯病患者前往西班牙和其他欧洲国家的移民潮迫使医务人员寻求解决这一新兴问题的办法。

干预措施

在这种背景下,得益于西班牙的国际合作,2009年创建了玻利维亚成年人恰加斯病综合护理平台。基于在ChNP总体指导方针框架下建立的垂直护理系统,在不同的流行病学背景下设立了六个专门管理恰加斯病的中心。一个通用数据库、标准化临床表格、针对成年患者的规范化护理,以及针对卫生专业人员的培训活动对于该模式的成功至关重要。通过地方病流行国家和非流行国家之间的合作及知识转移活动,该平台旨在提供护理、培训卫生专业人员,并为未来将经过验证的成年恰加斯病护理模式扩展到国家卫生系统奠定基础。

结果

2010年至2015年期间,该平台共接待了26,227名患者,69%(18,316名)被诊断为感染克氏锥虫,8,567人开始接受抗寄生虫治疗,培训了1,616多名卫生专业人员,并开展了十多个研究项目。该项目有助于增加被诊断和治疗的成年恰加斯病患者数量,制定基于证据的临床实践指南,并带来政策变化,从而增加成年恰加斯病患者获得综合护理的机会。ChNP目前正在研究该平台的医疗保健模式,以便在全国范围内进行调整和实施。

结论

这一策略为满足恰加斯病患者未得到满足的护理需求提供了解决方案,改善了诊断和治疗的可及性。进一步扩大诊断和治疗将基于把护理模式扩展到国家卫生系统结构。其可持续性将得到保障,因为它将依托玻利维亚现有的当地资源。不过,人力培训资源稀缺,玻利维亚的人员流动率高是该模式的一个局限。尽管如此,在初步扩大该模式的两年经验中,这些局限已与当地卫生当局共同在当地得到解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/f95a2dbd5d79/pntd.0005770.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/79050a48dd2d/pntd.0005770.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/da7228dd6301/pntd.0005770.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/f95a2dbd5d79/pntd.0005770.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/79050a48dd2d/pntd.0005770.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/da7228dd6301/pntd.0005770.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca1/5576759/f95a2dbd5d79/pntd.0005770.g003.jpg

相似文献

1
A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform.在流行国家扩大对成年恰加斯病患者全面护理的获取途径的策略:玻利维亚恰加斯病平台
PLoS Negl Trop Dis. 2017 Aug 18;11(8):e0005770. doi: 10.1371/journal.pntd.0005770. eCollection 2017 Aug.
2
Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network.结果和评价:在国家卫生系统内扩大综合性恰加斯病护理模式:玻利维亚恰加斯病网络。
PLoS Negl Trop Dis. 2022 Feb 17;16(2):e0010072. doi: 10.1371/journal.pntd.0010072. eCollection 2022 Feb.
3
Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia.新兴国家国家医疗保健系统的策略:以玻利维亚肾脏疾病进展的筛查与预防为例。
Kidney Int Suppl. 2005 Aug(97):S87-94. doi: 10.1111/j.1523-1755.2005.09715.x.
4
Congenital Chagas disease in a non-endemic area: Results from a control programme in Bergamo province, Northern Italy.先天性恰加斯病在非流行地区:意大利北部贝加莫省控制规划的结果。
Travel Med Infect Dis. 2018 Sep-Oct;25:31-34. doi: 10.1016/j.tmaid.2018.04.011. Epub 2018 Apr 20.
5
Family cluster of Chagas disease among Bolivian immigrants in Italy: High rate of maternal-fetal transmission.意大利玻利维亚移民中的恰加斯病家族聚集:母婴传播率高。
Travel Med Infect Dis. 2022 Sep-Oct;49:102370. doi: 10.1016/j.tmaid.2022.102370. Epub 2022 Jun 8.
6
Control and management of congenital Chagas disease in Europe and other non-endemic countries: current policies and practices.欧洲及其他非流行国家先天性恰加斯病的控制与管理:现行政策与实践
Trop Med Int Health. 2016 May;21(5):590-6. doi: 10.1111/tmi.12687. Epub 2016 Mar 17.
7
[Tuberculosis in Asia].[亚洲的结核病]
Kekkaku. 2002 Oct;77(10):693-7.
8
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.全球化新时代的查加斯病全球控制和管理:先天性克氏锥虫感染的深入观察。
Clin Microbiol Rev. 2022 Apr 20;35(2):e0015221. doi: 10.1128/cmr.00152-21. Epub 2022 Mar 3.
9
Anthropological study on Chagas Disease: Sociocultural construction of illness and embodiment of health barriers in Bolivian migrants in Rome, Italy.《关于恰加斯病的人类学研究:意大利罗马的玻利维亚移民中的疾病的社会文化构建和健康障碍的体现》。
PLoS One. 2020 Oct 16;15(10):e0240831. doi: 10.1371/journal.pone.0240831. eCollection 2020.
10
Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009.实施玻利维亚国家先天性克氏锥虫病防治规划的成就与挑战:2004-2009 年结果。
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2304. doi: 10.1371/journal.pntd.0002304. Print 2013.

引用本文的文献

1
Chagas disease in Brazil: new challenges and perspectives for old problems.巴西的恰加斯病:旧问题面临的新挑战与新前景。
Mem Inst Oswaldo Cruz. 2025 Jul 18;120:e240279. doi: 10.1590/0074-02760240279. eCollection 2025.
2
Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia.玻利维亚科恰班巴慢性恰加斯病患者的 5 年血清学和临床演变。
PLoS Negl Trop Dis. 2023 Dec 29;17(12):e0011498. doi: 10.1371/journal.pntd.0011498. eCollection 2023 Dec.
3
Design and feasibility of an implementation strategy to address Chagas guidelines engagement focused on attending women of childbearing age and children at the primary healthcare level in Argentina: a pilot study.

本文引用的文献

1
2 nd Brazilian Consensus on Chagas Disease, 2015.2015年第二届巴西恰加斯病共识
Rev Soc Bras Med Trop. 2016 Dec;49Suppl 1(Suppl 1):3-60. doi: 10.1590/0037-8682-0505-2016.
2
Chagas disease in Latin America: an epidemiological update based on 2010 estimates.拉丁美洲的恰加斯病:基于2010年估计数的流行病学最新情况。
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43.
3
Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.用于评估恰加斯病治疗效果的生物学标志物:系统评价。
设计并验证在阿根廷基层医疗层面实施一种以关注育龄期妇女和儿童为重点的恰加斯病防治指南参与策略的可行性:一项试点研究。
BMC Prim Care. 2022 Nov 8;23(1):277. doi: 10.1186/s12875-022-01886-6.
4
Long-Standing International Cooperation in Parasitology Research: A Summary of 35 Years of Activities in the Bolivian Chaco.寄生虫学研究领域的长期国际合作:玻利维亚查科地区35年活动总结
Trop Med Infect Dis. 2022 Sep 29;7(10):275. doi: 10.3390/tropicalmed7100275.
5
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.一项评估口服非达霉素治疗慢性不定型恰加斯病成人患者的 2 期、随机、多中心、安慰剂对照、概念验证临床试验。
Clin Infect Dis. 2023 Feb 8;76(3):e1186-e1194. doi: 10.1093/cid/ciac579.
6
Population movements, borders, and Chagas disease.人口流动、边界和恰加斯病。
Mem Inst Oswaldo Cruz. 2022 Jul 8;117:e210151. doi: 10.1590/0074-02760210151. eCollection 2022.
7
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment.恰加斯病的转化研究:从硒补充研究中出现的营养治疗新视角,作为一种补充治疗。
Mem Inst Oswaldo Cruz. 2022 Mar 21;117:e220001. doi: 10.1590/0074-02760220001. eCollection 2022.
8
Results and evaluation of the expansion of a model of comprehensive care for Chagas disease within the National Health System: The Bolivian Chagas network.结果和评价:在国家卫生系统内扩大综合性恰加斯病护理模式:玻利维亚恰加斯病网络。
PLoS Negl Trop Dis. 2022 Feb 17;16(2):e0010072. doi: 10.1371/journal.pntd.0010072. eCollection 2022 Feb.
9
New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.新型抗恰加斯病化疗方案和生物标志物:TESEO 研究的原理和设计,一项在玻利维亚多民族国开展的开放标签、随机、前瞻性、2 期临床试验。
BMJ Open. 2021 Dec 31;11(12):e052897. doi: 10.1136/bmjopen-2021-052897.
10
Chagas Disease in HIV-Infected Patients: It's Time to Consider the Diagnosis.HIV感染患者的恰加斯病:是时候考虑诊断了。
Am J Trop Med Hyg. 2021 Aug 16;105(3):545-546. doi: 10.4269/ajtmh.21-0681.
Expert Rev Anti Infect Ther. 2014 Apr;12(4):479-96. doi: 10.1586/14787210.2014.899150.
4
Towards a paradigm shift in the treatment of chronic Chagas disease.向慢性恰加斯病治疗范式的转变。
Antimicrob Agents Chemother. 2014;58(2):635-9. doi: 10.1128/AAC.01662-13. Epub 2013 Nov 18.
5
Socio-cultural aspects of Chagas disease: a systematic review of qualitative research.《恰加斯病的社会文化方面:定性研究的系统评价》
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2410. doi: 10.1371/journal.pntd.0002410. eCollection 2013.
6
Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009.实施玻利维亚国家先天性克氏锥虫病防治规划的成就与挑战:2004-2009 年结果。
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2304. doi: 10.1371/journal.pntd.0002304. Print 2013.
7
Tolerance and safety of nifurtimox in patients with chronic chagas disease.硝呋替莫治疗慢性恰加斯病患者的耐受性和安全性。
Clin Infect Dis. 2010 Nov 15;51(10):e69-75. doi: 10.1086/656917. Epub 2010 Oct 8.
8
Tolerance of benznidazole in treatment of Chagas' disease in adults.苯硝唑治疗成人恰加斯病的耐受性。
Antimicrob Agents Chemother. 2010 Nov;54(11):4896-9. doi: 10.1128/AAC.00537-10. Epub 2010 Sep 7.
9
Evaluation and treatment of chagas disease in the United States: a systematic review.美国恰加斯病的评估与治疗:一项系统评价
JAMA. 2007 Nov 14;298(18):2171-81. doi: 10.1001/jama.298.18.2171.
10
Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina.克氏锥虫感染患者的病因治疗:阿根廷的经验
Curr Opin Infect Dis. 2006 Dec;19(6):583-7. doi: 10.1097/01.qco.0000247592.21295.a5.